Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety monitoring study of compound matrine injection
ChiCTR-OPC-15006782Phase 4Completed
- Sponsor
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
- Start
- Mar 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of matrine in cancer, sponsored by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences. Primary endpoint: Any adverse events. Started Mar 2015; status: completed.
02
Drugs
matrine
03
Conditions
cancer
Beyond the preview
Go deeper on ChiCTR-OPC-15006782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006782.